๐—จ๐—ป๐—ฑ๐—ฒ๐—ฟ๐˜€๐˜๐—ฎ๐—ป๐—ฑ๐—ถ๐—ป๐—ด ๐˜†๐—ผ๐˜‚๐—ฟ ๐—ด๐—ฒ๐—ป๐—ฒ๐˜๐—ถ๐—ฐ ๐—ฟ๐—ถ๐˜€๐—ธ ๐—ถ๐˜€ ๐˜๐—ต๐—ฒ ๐—ณ๐—ถ๐—ฟ๐˜€๐˜ ๐˜€๐˜๐—ฒ๐—ฝ ๐˜๐—ผ๐˜„๐—ฎ๐—ฟ๐—ฑ๐˜€ ๐—ฒ๐—ณ๐—ณ๐—ฒ๐—ฐ๐˜๐—ถ๐˜ƒ๐—ฒ ๐—ฝ๐—ฟ๐—ฒ๐˜ƒ๐—ฒ๐—ป๐˜๐—ถ๐—ผ๐—ป.

While cancer can develop in anyone as a result of environmental factors or ageing, individuals with Lynch syndrome carry an inherited genetic variant that impairs the bodyโ€˜s ability to repair DNA replication errors. This mismatch repair deficiency substantially increases the lifetime risk of developing colorectal, endometrial and other cancers, frequently at an earlier age than in the general population.

PREDI-LYNCH was established to address precisely this difference: standard screening protocols are not sufficient for high-risk families, and precision tools adapted to genetic risk are required.

Learn more at https://predi-lynch.eu/

Leave a comment